Description
HeSANDA 1.0.0
To study is a double-blind, randomised, placebo-controlled trial of daily oral melatonin administration from 39 weeks' gestation in nulliparous pregnant women to reduce induction of labour rates. Induction of labour will be the primary endpoint of the study.
To study is a double-blind, randomised, placebo-controlled trial of daily oral melatonin administration from 39 weeks' gestation in nulliparous pregnant women to reduce induction of labour rates. Induction of labour will be the primary endpoint of the study.
Date made available | 2024 |
---|---|
Publisher | Curtin University |
Geographical coverage | Australia |